Search hospitals > New York > Brooklyn
New York Methodist Hospital
Claim this profileBrooklyn, New York 11215
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Prostate Cancer
Conducts research for Lung Cancer
Conducts research for Heart Failure
218 reported clinical trials
14 medical researchers
Summary
New York Methodist Hospital is a medical facility located in Brooklyn, New York. This center is recognized for care of Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Heart Failure and other specialties. New York Methodist Hospital is involved with conducting 218 clinical trials across 299 conditions. There are 14 research doctors associated with this hospital, such as Hani Ashamalla, M.D., Scott Tagawa, MD, Margaux J. Kanis, and Uqba Khan.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
ER positive
HER2 positive
Top PIs
Hani Ashamalla, M.D.Brooklyn Methodist Hospital - NewYork Presbyterian2 years of reported clinical research
Studies Breast Cancer
Studies Cancer
18 reported clinical trials
46 drugs studied
Scott Tagawa, MDWeill Cornell Medical College3 years of reported clinical research
Expert in Prostate Cancer
Studies Kidney Cancer
13 reported clinical trials
23 drugs studied
Margaux J. KanisNew York-Presbyterian/Brooklyn Methodist Hospital4 years of reported clinical research
Studies Adenocarcinoma
Studies Serous Cystadenocarcinoma
3 reported clinical trials
7 drugs studied
Uqba KhanNew York-Presbyterian/Brooklyn Methodist Hospital4 years of reported clinical research
Studies Colorectal Cancer
Studies Adenocarcinoma
4 reported clinical trials
15 drugs studied
Clinical Trials running at New York Methodist Hospital
Breast Cancer
Bladder Carcinoma
Non-Small Cell Lung Cancer
Bladder Cancer
Lung Cancer
Prostate Cancer
Renal Cell Carcinoma
Cancer
Colorectal Cancer
Rectal Cancer
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Accelerated Radiation Therapy
for Breast Cancer
Patients with Stage 0 ductal carcinoma in situ (Tis (DCIS), Stage T1-T2, lymph node negative(N0) breast cancers will be randomized to receive whole breast radiotherapy with a concomitant boost to the tumor bed over 15 fractions (Arm 1, standard) versus 10 fractions (Arm 2, experimental).
Recruiting2 awards Phase 31 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at New York Methodist Hospital?
New York Methodist Hospital is a medical facility located in Brooklyn, New York. This center is recognized for care of Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Heart Failure and other specialties. New York Methodist Hospital is involved with conducting 218 clinical trials across 299 conditions. There are 14 research doctors associated with this hospital, such as Hani Ashamalla, M.D., Scott Tagawa, MD, Margaux J. Kanis, and Uqba Khan.